Literature DB >> 12559119

Taurine-induced synaptic potentiation and the late phase of long-term potentiation are related mechanistically.

N del Olmo1, A Handler, L Alvarez, J Bustamante, R Martín del Río, J M Solís.   

Abstract

The application of taurine (2-aminoethanesulfonic acid) induces a long-lasting increase of synaptic efficacy and axon excitability (LLP-TAU) in rat hippocampal CA1 area. After taurine withdrawal, LLP-TAU lasted at least 3 h. This fact prompted us to assess whether the mechanisms involved in the maintenance of this particular potentiation were similar to those implicated in the late phase of long-term potentiation (L-LTP). In the presence of KN-62, an inhibitor of calcium/calmodulin-dependent protein kinase, taurine perfusion (10 mM, 30 min) did not affect the induction of LLP-TAU. However, LLP-TAU maintenance was completely suppressed by KT5720, an inhibitor of the cAMP-dependent protein kinase (PKA). Moreover, the late phase of LLP-TAU was blocked by inhibiting protein synthesis with anisomycin. In addition, taurine perfusion increased the phosphorylation of cAMP response element-binding protein (CREB), although did not affect cAMP levels. These features of LLP-TAU do not appear to be caused by the activation of D1/D5 dopamine receptors, as taurine also induced synaptic potentiation in the presence of SCH23390, an antagonist of this type of receptors. Finally, the late phase of both L-LTP and LLP-TAU occluded mutually. These results suggest that taurine triggers the sequence of some of the molecular events involved in the induction of L-LTP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559119     DOI: 10.1016/s0028-3908(02)00310-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

1.  Role of glycine receptors in glycine-induced LTD in hippocampal CA1 pyramidal neurons.

Authors:  Rong-Qing Chen; Shan-Hui Wang; Wen Yao; Jing-Jing Wang; Fang Ji; Jing-Zhi Yan; Si-Qiang Ren; Zheng Chen; Su-Yi Liu; Wei Lu
Journal:  Neuropsychopharmacology       Date:  2011-05-18       Impact factor: 7.853

2.  Optimal excitation and emission wavelengths to analyze amino acids and optimize neurotransmitters quantification using precolumn OPA-derivatization by HPLC.

Authors:  J Perucho; R Gonzalo-Gobernado; E Bazan; M J Casarejos; A Jiménez-Escrig; M J Asensio; A S Herranz
Journal:  Amino Acids       Date:  2015-02-18       Impact factor: 3.520

Review 3.  Taurine as an Essential Neuromodulator during Perinatal Cortical Development.

Authors:  Werner Kilb; Atsuo Fukuda
Journal:  Front Cell Neurosci       Date:  2017-10-24       Impact factor: 5.505

4.  Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.

Authors:  Yuning Che; Liyan Hou; Fuqiang Sun; Cong Zhang; Xiaofang Liu; Fengyuan Piao; Dan Zhang; Huihua Li; Qingshan Wang
Journal:  Cell Death Dis       Date:  2018-04-01       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.